Array Biopharma Inc (ARRY) Raised to Hold at Vetr Inc.


The firm currently has a $9.99 target price on the biopharmaceutical company's stock. Vetr 's price target indicates a potential downside of 0.79% from the stock's current price.



from Biotech News